Cargando…
Combined application of Embelin and tumor necrosis factor-related apoptosis-inducing ligand inhibits proliferation and invasion in osteosarcoma cells via caspase-induced apoptosis
Embelin, as an inhibitor of the X-linked inhibitor of apoptosis protein (XIAP), may induce apoptosis in various types of cancer cells. The present study aimed to determine the effect of Embelin on the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of osteosarcoma c...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921233/ https://www.ncbi.nlm.nih.gov/pubmed/29731867 http://dx.doi.org/10.3892/ol.2018.8209 |
_version_ | 1783317965494550528 |
---|---|
author | Qian, Hao Chen, Yao Huang, Tao Liu, Tiemin Li, Xiucheng Jiang, Guangjian Zhang, Wei Cheng, Shuo Li, Pengcheng |
author_facet | Qian, Hao Chen, Yao Huang, Tao Liu, Tiemin Li, Xiucheng Jiang, Guangjian Zhang, Wei Cheng, Shuo Li, Pengcheng |
author_sort | Qian, Hao |
collection | PubMed |
description | Embelin, as an inhibitor of the X-linked inhibitor of apoptosis protein (XIAP), may induce apoptosis in various types of cancer cells. The present study aimed to determine the effect of Embelin on the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of osteosarcoma cells. Embelin and TRAIL were applied to U2OS and MG63 cells, respectively or in combination. MTT was initially used to detect the difference in survival rates between the group receiving combined application of 100 ng/ml TRAIL and 20 µmol/l Embelin and the individual application groups. Light microscopic quantification was used to detect the morphology of the osteosarcoma cells in each group. Determination of cell apoptosis was subsequently performed using flow cytometry. The invasive ability of the cells was detected by a Transwell assay, prior to relative protein expression being determined by western blot analysis. Based on all the test data, it was revealed that the survival rates and the invasive ability were significantly lower following the combined application of 100 ng/ml TRAIL and 20 µmol/l Embelin than following the individual application of either (P<0.01). Additionally, upregulating expression of caspases, as well as death receptor 5, and downregulating expression of XIAP and matrix metalloproteinase 9 (MMP-9), had more significant effects in the combined group compared with the individual group and the control group. All these results suggested that Embelin may enhance TRAIL-induced apoptosis and inhibit the invasion of human osteosarcoma cells. |
format | Online Article Text |
id | pubmed-5921233 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-59212332018-05-04 Combined application of Embelin and tumor necrosis factor-related apoptosis-inducing ligand inhibits proliferation and invasion in osteosarcoma cells via caspase-induced apoptosis Qian, Hao Chen, Yao Huang, Tao Liu, Tiemin Li, Xiucheng Jiang, Guangjian Zhang, Wei Cheng, Shuo Li, Pengcheng Oncol Lett Articles Embelin, as an inhibitor of the X-linked inhibitor of apoptosis protein (XIAP), may induce apoptosis in various types of cancer cells. The present study aimed to determine the effect of Embelin on the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of osteosarcoma cells. Embelin and TRAIL were applied to U2OS and MG63 cells, respectively or in combination. MTT was initially used to detect the difference in survival rates between the group receiving combined application of 100 ng/ml TRAIL and 20 µmol/l Embelin and the individual application groups. Light microscopic quantification was used to detect the morphology of the osteosarcoma cells in each group. Determination of cell apoptosis was subsequently performed using flow cytometry. The invasive ability of the cells was detected by a Transwell assay, prior to relative protein expression being determined by western blot analysis. Based on all the test data, it was revealed that the survival rates and the invasive ability were significantly lower following the combined application of 100 ng/ml TRAIL and 20 µmol/l Embelin than following the individual application of either (P<0.01). Additionally, upregulating expression of caspases, as well as death receptor 5, and downregulating expression of XIAP and matrix metalloproteinase 9 (MMP-9), had more significant effects in the combined group compared with the individual group and the control group. All these results suggested that Embelin may enhance TRAIL-induced apoptosis and inhibit the invasion of human osteosarcoma cells. D.A. Spandidos 2018-05 2018-03-08 /pmc/articles/PMC5921233/ /pubmed/29731867 http://dx.doi.org/10.3892/ol.2018.8209 Text en Copyright: © Qian et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Articles Qian, Hao Chen, Yao Huang, Tao Liu, Tiemin Li, Xiucheng Jiang, Guangjian Zhang, Wei Cheng, Shuo Li, Pengcheng Combined application of Embelin and tumor necrosis factor-related apoptosis-inducing ligand inhibits proliferation and invasion in osteosarcoma cells via caspase-induced apoptosis |
title | Combined application of Embelin and tumor necrosis factor-related apoptosis-inducing ligand inhibits proliferation and invasion in osteosarcoma cells via caspase-induced apoptosis |
title_full | Combined application of Embelin and tumor necrosis factor-related apoptosis-inducing ligand inhibits proliferation and invasion in osteosarcoma cells via caspase-induced apoptosis |
title_fullStr | Combined application of Embelin and tumor necrosis factor-related apoptosis-inducing ligand inhibits proliferation and invasion in osteosarcoma cells via caspase-induced apoptosis |
title_full_unstemmed | Combined application of Embelin and tumor necrosis factor-related apoptosis-inducing ligand inhibits proliferation and invasion in osteosarcoma cells via caspase-induced apoptosis |
title_short | Combined application of Embelin and tumor necrosis factor-related apoptosis-inducing ligand inhibits proliferation and invasion in osteosarcoma cells via caspase-induced apoptosis |
title_sort | combined application of embelin and tumor necrosis factor-related apoptosis-inducing ligand inhibits proliferation and invasion in osteosarcoma cells via caspase-induced apoptosis |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921233/ https://www.ncbi.nlm.nih.gov/pubmed/29731867 http://dx.doi.org/10.3892/ol.2018.8209 |
work_keys_str_mv | AT qianhao combinedapplicationofembelinandtumornecrosisfactorrelatedapoptosisinducingligandinhibitsproliferationandinvasioninosteosarcomacellsviacaspaseinducedapoptosis AT chenyao combinedapplicationofembelinandtumornecrosisfactorrelatedapoptosisinducingligandinhibitsproliferationandinvasioninosteosarcomacellsviacaspaseinducedapoptosis AT huangtao combinedapplicationofembelinandtumornecrosisfactorrelatedapoptosisinducingligandinhibitsproliferationandinvasioninosteosarcomacellsviacaspaseinducedapoptosis AT liutiemin combinedapplicationofembelinandtumornecrosisfactorrelatedapoptosisinducingligandinhibitsproliferationandinvasioninosteosarcomacellsviacaspaseinducedapoptosis AT lixiucheng combinedapplicationofembelinandtumornecrosisfactorrelatedapoptosisinducingligandinhibitsproliferationandinvasioninosteosarcomacellsviacaspaseinducedapoptosis AT jiangguangjian combinedapplicationofembelinandtumornecrosisfactorrelatedapoptosisinducingligandinhibitsproliferationandinvasioninosteosarcomacellsviacaspaseinducedapoptosis AT zhangwei combinedapplicationofembelinandtumornecrosisfactorrelatedapoptosisinducingligandinhibitsproliferationandinvasioninosteosarcomacellsviacaspaseinducedapoptosis AT chengshuo combinedapplicationofembelinandtumornecrosisfactorrelatedapoptosisinducingligandinhibitsproliferationandinvasioninosteosarcomacellsviacaspaseinducedapoptosis AT lipengcheng combinedapplicationofembelinandtumornecrosisfactorrelatedapoptosisinducingligandinhibitsproliferationandinvasioninosteosarcomacellsviacaspaseinducedapoptosis |